Get access

“Collaborative Innovation”—Regaining the Edge in Drug Discovery

Authors

  • Prof. Dr. Hanno Wild,

    Corresponding author
    1. Bayer HealthCare AG, Global Drug Discovery, Global Candidate Generation and Exploration, 42096 Wuppertal (Germany)
    • Bayer HealthCare AG, Global Drug Discovery, Global Candidate Generation and Exploration, 42096 Wuppertal (Germany)
    Search for more papers by this author
  • Dr. Christoph Huwe,

    1. Bayer HealthCare AG, Global Drug Discovery, Global Candidate Generation and Exploration, 42096 Wuppertal (Germany)
    Search for more papers by this author
  • Dr. Monika Lessl

    1. Bayer HealthCare AG, Global Drug Discovery, Global Candidate Generation and Exploration, 42096 Wuppertal (Germany)
    Search for more papers by this author

Abstract

Sharers are winners: The concept of “Collaborative Innovation” has the potential to overcome the significant challenges the pharmaceutical industry faces in its effort to improve the lives of patients by fighting increasingly complex diseases. In order to succeed, it is crucial to join forces on a global level and to combine different approaches in a flexible way, requiring the right mindset of all involved parties, a combination of internal excellence and external openness, and the right organizational setup.

Ancillary